Ustekinumab for the Treatment of Giant Cell Arteritis
Clinical trial NCT02955147 · TERMINATED
Trial details
- NCT number
- NCT02955147
- Sponsor
- Massachusetts General Hospital
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2019-07-25
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.